Loading the session
Loading the session
Loading instrument
$24.95
+0.00%Delayed · Pre-marketDelayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 16:00 IST · A quote does not mean the product is available to trade on your account.
Opens 8:00 pm IST
Opens 8:00 pm IST
Opens 8:00 pm IST
In brief
Questions investors ask
Quotes run fifteen minutes behind.
Closed at $24.95 on 4 Nov 2026: 3.7% below the 52-week high of $25.92 (4 Nov 2026) and 117.3% above the low of $11.48 (11 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026
1 month: +27.6% (SPY −1.6%, XLV +13.5%). 3 months: +38.3% (SPY −0.4%, XLV +15.5%). 1 year: +62.5% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: SIBN, SPY and XLV · as of 4 Nov 2026
4.7M shares were sold short at the 15 Oct 2026 settlement, 10.6% of the 44.3M shares outstanding; covering them would take 8.7 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
4 Nov 2026 volume of 2.2M shares was 3.0× the average of the 30 sessions before it (724.2K), as the price rose 5.0%. SPY traded 1.5× its own average that session.
Daily volume against a 30-session baseline · as of 4 Nov 2026
The 4 Nov 2026 close of $24.95 was 27.2% above its 50-day average ($19.61) and 51.4% above its 200-day average ($16.48). It has closed above the 200-day for 97 sessions, since 18 Jun 2026. The 50-day average crossed above the 200-day on 28 Jul 2026, 70 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
Price return, split-adjusted
At the 4 Nov 2026 close
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
May 12, 2026
+19.72%November 10, 2022
+18.97%November 8, 2022
−24.33%